Alnylam Pharmaceuticals (ALNY) is down 4.6% today. Here is some analysis on what might have caused this price movement.

Brainomix, a leading medtech company specializing in AI-powered imaging tools for lung disease and stroke, today announced new data published in the esteemed American Journal of Respiratory & Critical ...

OptionMetrics' IvyDB TradeFlow classifies US options buying and selling pressure and retail vs institutional participation in ...

CeriBell, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared new software for the Ceribell System that makes it easier and faster for clinicians to interpret longitudinal ...

Plus500 reports October is the most volatile month for the stock market, historically showing an average positive return, ...

Measuring WCET in multicore systems by Jay Thomas, Senior Director of Field Engineering, TASKING, and Gerard Vink, Industry Specialist, TASKING In part 1 and part 2 of this article series, we ...

Designed specifically for financial use-cases, ProntoNLP processes large quantities of information, and makes it actionable.

The global medical image analysis software market is projected to grow from USD 4.2 billion in 2026 to USD 6.3 billion by ...

Volume 42 of SLAS Discovery includes one review, eight original research articles and 1 short communication for oncology, ...

INTEGRA's automated solutions optimize CRISPR workflows, enhancing gene editing efficiency and accelerating the path to ...

Detailed price information for Robinhood Markets Cl A (HOOD-Q) from The Globe and Mail including charting and trades.

AI-enabled digital pathology analysis shows aglatimagene significantly increased lymphocyte infiltration and immune engagement with tumor cells ...